Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
107M
-
Number of holders
-
113
-
Total 13F shares, excl. options
-
66.1M
-
Shares change
-
-33.6K
-
Total reported value, excl. options
-
$303M
-
Value change
-
-$1.04M
-
Put/Call ratio
-
4
-
Number of buys
-
58
-
Number of sells
-
-45
-
Price
-
$4.59
Significant Holders of MAXCYTE, INC. - Common Stock, par value $0.01 per share (MXCT) as of Q2 2023
124 filings reported holding MXCT - MAXCYTE, INC. - Common Stock, par value $0.01 per share as of Q2 2023.
MAXCYTE, INC. - Common Stock, par value $0.01 per share (MXCT) has 113 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 66.1M shares
of 107M outstanding shares and own 61.87% of the company stock.
Largest 10 shareholders include BlackRock Inc. (6.92M shares), Vitruvian Partners LLP (5.04M shares), VANGUARD GROUP INC (4.97M shares), Casdin Capital, LLC (4.72M shares), Stonepine Capital Management, LLC (3.97M shares), ArrowMark Colorado Holdings LLC (2.58M shares), Holocene Advisors, LP (2.12M shares), MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (1.95M shares), MILLENNIUM MANAGEMENT LLC (1.94M shares), and Granahan Investment Management, LLC (1.89M shares).
This table shows the top 113 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.